Form 4 for CDNA CareDx, Inc.
Accepted 2026-06-16 17:51:28 ET · period of report 2026-06-12 · accession 0001855608-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-16 17:51 | 2026-06-12 | CDNA | Valantine Hannah | Dir | A - Grant | $0.00 | +9,795 | 48.8K | +25% | $0 |
| T | 2026-06-16 17:51 | 2026-06-15 | CDNA | Valantine Hannah | Dir | S - Sale | $23.11 | -12.1K | 36.7K | -25% | -$279.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | A | A | 9,795 | $0.00 | 48,789 | D | — | — | (F1) The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date. |
| 2 | Common | Common Stock | 2026-06-15 | S | D | 12,103 | $23.11 | 36,686 | D | — | — | (F2) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |